Detection of SARS-CoV-2 IgG antibodies and inflammatory cytokines in saliva-a pilot study

[1]  Xiang Yu,et al.  Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren’s syndrome , 2022, BMC Immunology.

[2]  Ayham Al Afif,et al.  Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic , 2022, European Archives of Oto-Rhino-Laryngology.

[3]  C. Hopkins,et al.  New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID‐19 After Complete Vaccination , 2021, The Laryngoscope.

[4]  H. Tsuchiya.  Characterization and Pathogenic Speculation of Xerostomia Associated with COVID-19: A Narrative Review , 2021, Dentistry journal.

[5]  A. Casadevall,et al.  Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers , 2021, Journal of Clinical Virology.

[6]  Menira Souza,et al.  Validity and reliability of immunochromatographic IgM/IgG rapid tests for COVID‐19 salivary diagnosis , 2021, Oral diseases.

[7]  A. Acevedo,et al.  Oral Manifestations in Patients with COVID-19: A 6-Month Update , 2021, Journal of dental research.

[8]  Daniel S. Chertow,et al.  SARS-CoV-2 infection of the oral cavity and saliva , 2021, Nature Medicine.

[9]  F. Ciceri,et al.  Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19 , 2021, Journal of dental research.

[10]  F. Atoof,et al.  Xerostomia (dry mouth) in patients with COVID-19: a case series , 2021, Future Virology.

[11]  Y. Benjamini,et al.  Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients , 2021, Clinical Microbiology and Infection.

[12]  O. Kharbanda,et al.  Exploring salivary diagnostics in COVID-19: a scoping review and research suggestions , 2021, BDJ open.

[13]  Jocelyn T. Kim,et al.  Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients , 2021, Frontiers in Immunology.

[14]  O. Kharbanda,et al.  Saliva and COVID 19: Current dental perspective , 2021, Journal of oral and maxillofacial pathology : JOMFP.

[15]  Xuedong Zhou,et al.  The positive rate of saliva for the detection of 2019‐nCoV and possible factors related to the sensitivity results , 2020, Journal of medical virology.

[16]  H. Jarva,et al.  Saliva‐based testing for diagnosis of SARS‐CoV‐2 infection: A meta‐analysis , 2020, Journal of medical virology.

[17]  O. Laeyendecker,et al.  COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva , 2020, Journal of Clinical Microbiology.

[18]  A. Acevedo,et al.  Oral Manifestations in Patients with COVID-19: A Living Systematic Review , 2020, Journal of dental research.

[19]  R. Pampena,et al.  Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19☆☆☆ , 2020, American Journal of Otolaryngology.

[20]  B. Rubin,et al.  A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients , 2020, Journal of Clinical Microbiology.

[21]  G. Zuccotti,et al.  Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature , 2020, Ear, nose, & throat journal.

[22]  Elizabeth B White,et al.  Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 , 2020, The New England journal of medicine.

[23]  R. Lai,et al.  Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay , 2020, Journal of Clinical Virology.

[24]  R. Orlandi,et al.  Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2 , 2020, Journal of Clinical Microbiology.

[25]  P. Thomson,et al.  ‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers , 2020, Medical Hypotheses.

[26]  Shaoying Huang,et al.  The cytokine storm and COVID‐19 , 2020, Journal of medical virology.

[27]  M. Sanz,et al.  Is the oral cavity relevant in SARS-CoV-2 pandemic? , 2020, Clinical Oral Investigations.

[28]  Mark J. Ponsford,et al.  Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection , 2020, medRxiv.

[29]  Yongdi Li,et al.  Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS‐CoV‐2 , 2020, Journal of medical virology.

[30]  Xuedong Zhou,et al.  Transmission routes of 2019-nCoV and controls in dental practice , 2020, International Journal of Oral Science.

[31]  Taiwen Li,et al.  High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.

[32]  B. Schmidt,et al.  Targeted TNF-α Overexpression Drives Salivary Gland Inflammation , 2019, Journal of dental research.

[33]  I. Gherghina,et al.  Update in immunology. , 2011, Maedica.

[34]  J. Anaya,et al.  Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism. , 2002, The Journal of rheumatology.

[35]  A. Altman,et al.  Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. , 1985, Journal of immunology.